Physician profile
Jayme Gardner
NPI 1700274594
$1,237.62
in general payments reported to CMS, 2019-2025
18 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.82 · 2022: $114 · 2023: $268 · 2024: $421 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,038.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.45 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $185.67 | 2021-2024 | Xarelto |
| Ucb, INC. | $140.15 | 2023-2025 | Briviact, Fintepla |
| Novartis Pharmaceuticals Corporation | $68.54 | 2021-2025 | |
| Inspire Medical Systems, INC. | $66.48 | 2025 | Inspire |
| Argenx US, INC. | $38.11 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $33.49 | 2022-2024 | |
| Lilly USA, LLC | $33.03 | 2023 | Emgality |
| Immedica Pharma US, INC. | $29.36 | 2023 | |
| Neurocrine Biosciences, INC. | $26.69 | 2024 | Ingrezza |
| Amgen INC. | $23.65 | 2024 | Uplizna |
| Greenwich Biosciences, INC. | $23.34 | 2021 | |
| Horizon Therapeutics Plc | $23.12 | 2023 | Uplizna |
| Jazz Pharmaceuticals INC. | $21.87 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $17.09 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $16.89 | 2022 | |
| Abbott Laboratories | $16.09 | 2023 | Jot Dx |
| Supernus Pharmaceuticals, INC. | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayme Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.